Oral Abstract
Kidney Chronic Rejection

Wednesday August 06, 2025 | 08:15 to 09:30
Room: 155
Track: Allied Health

Presentations

Rajalingam Raja, United States
High-Affinity NK Cell IgG Receptors and De Novo DSA Are Linked to Poor Kidney Transplant Outcomes

Vaka Sigurjonsdottir
HLA-DQ: The Dominant Driver of De Novo Donor-Specific Antibody-Mediated Graft Failure in Pediatric Kidney Transplantation

Luis Camacho Murillo, Mexico
First-Line Treatment in Patients with Chronic-Active Antibody-Mediated Rejection Confers Similar Kidney Graft Survival and Post-Transplant Glomerulopathy as Patients Without Chronicity

Philip Halloran, Canada
Defining the Hierarchy of Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection

Ivy Rosales, United States
Intra- and Extraglomerular Transcripts in Chronic Antibody Mediated Rejection Reveal Distinct Immune Responses

Alessia Giarraputo, France
Single-Cell Spatial Transcriptomics Reveal Intraglomerular Cell Activation and Ligand-Receptor Relationships in Chronic, Active Antibody Mediated Rejection

Michael Kueht, United States
Comparison of a Gene Expression Profiling Panel with Combined Histopathology and Microarrays to Classify Kidney Allograft Rejection

Wai Choong Lye, Singapore
Anti-CD38 Monoclonal Antibody Daratumumab for the Treatment of Chronic Active-Antibody Mediated Kidney Allograft Rejection

Email: info@wtc2025.org
514-874-1717